Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Just Released: The No. 1 Stock to Buy in 2020

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 622.85 3.43% 623.75 4.00%
 More Info 
AJANTA PHARMA 1,179.40 -0.27% 1,180.25 -0.22%
 More Info 
ALEMBIC PHARMA 590.20 0.03% 589.85 0.18%
 More Info 
BIOCON 294.45 0.08% 294.35 0.02%
 More Info 
CADILA HEALTHCARE 271.95 1.06% 272.15 1.00%
 More Info 
CIPLA 458.10 -1.44% 458.85 -1.35%
 More Info 
DIVIS LABORATORIES 1,912.10 0.76% 1,910.50 0.69%
 More Info 
DR. REDDYS LAB 3,028.05 -0.34% 3,031.40 -0.22%
 More Info 
GLENMARK PHARMA 350.80 0.03% 350.75 -0.04%
 More Info 
INDOCO REMEDIES 222.35 -4.51% 222.45 -4.73%
 More Info 
IPCA LABS 1,223.35 -0.19% 1,224.15 -0.19%
 More Info 
J.B.CHEMICALS 497.40 0.29% 496.00 -0.27%
 More Info 
LUPIN 740.10 0.27% 740.15 0.31%
 More Info 
NATCO PHARMA 660.10 1.75% 660.15 1.72%
 More Info 
NIFTY 50 Not Listed 12,248.25 0.56%
 More Info 
ORCHID PHARMA LTD 5.25 -4.89% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 129.25 -1.41% 129.45 -1.26%
 More Info 
PIRAMAL ENTERPRISES 1,676.55 -0.65% 1,675.40 -0.66%
 More Info 
S&P BSE SENSEX 41,613.19 0.55% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 414.75 0.61% 414.85 0.67%
 More Info 
SUN PHARMA 447.70 -0.49% 447.80 -0.46%
 More Info 
TORRENT PHARMA 2,036.90 0.75% 2,036.95 0.81%
 More Info 
WOCKHARDT 299.05 6.44% 299.00 6.39%
 More Info 

BSE prices: January 24, 2020  (Close)    NSE prices: January 24, 2020  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,290.1 (down 0.1%). The index is down 19.5% over the last 30 days. And over the last 1 year, it has lost 11.8%.

Within the Indian Pharma sector, the top gainers were WOCKHARDT (up 6.4%) and AARTI DRUGS (up 3.4%). On the other hand, INDOCO REMEDIES (down 4.5%) and CIPLA (down 1.4%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 12,248.3 (up 0.6%).




Today's Market

Buzz on the Street: A Look at Stocks, Sectors and the Economy(Podcast)

The stock markets in India remained rangebound this week. Economic data releases and third quarter results announcements were the focus of the week.

Related Views on News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

WOCKHARDT Surges by 5%; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Jan 24, 2020 | Updated on Jan 24, 2020

WOCKHARDT share price has surged by 5% and its current market price is Rs 296. The BSE HEALTHCARE is up by 0.4%. The top gainers in the BSE HEALTHCARE Index is WOCKHARDT (up 5.2%). The top losers are J.B.CHEMICALS and LAURUS LABS LTD (down 0.1%).

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Jan 24, 2020 (Close)

COMPARE COMPANY

MARKET STATS